Emer Cooke, EMA executive director (Geert Vanden Wijngaert/AP Images)

EMA re­views re­pur­posed ex­per­i­men­tal can­cer drug for Covid-19, even with­out a sub­mis­sion

In a rare move for any reg­u­la­tor, the Eu­ro­pean Med­i­cines Agency said Wednes­day it’s be­gun re­view­ing da­ta on the use of an ex­per­i­men­tal can­cer drug …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.